Turbocef 1.5 gm/vial (IV Injection)

1.5 gm vial: ৳ 200.00

Medicine Details

Indications

  • Treatment of infections caused by sensitive bacteria
  • Pharyngitis/Tonsillitis caused by Streptococcus pyogenes
  • Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis
  • Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae
  • Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella spp., Staphylococcus aureus, E. coli
  • Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae or Haemophilus parainfluenzae
  • Skin and skin-structure infections caused by Staphylococcus aureus or Streptococcus pyogenes
  • Urinary tract infections caused by E.coli or Klebsiella pneumoniae
  • Bone and Joint Infections caused by Staphylococcus aureus
  • Gonorrhoea caused by Neisseria gonorrhoeae
  • Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi

Pharmacology

  • Broad-spectrum bactericidal activity
  • Effective against β-lactamase producing strains
  • Good stability to bacterial β-lactamase
  • Active against many ampicillin-resistant and amoxycillin-resistant strains

Dosage

  • Tablet or Suspension:
    • Adolescents and adults (13 years and older)
    • Pediatric Patients (3 months to 12 years)
  • Parenteral:
    • Adult
    • Children (above 3 months of age)
    • Neonate
  • Meningitis:
    • Adult
    • Children (above 3 months of age)
    • Neonate
  • Bone and joint infections:
    • Adult
    • Children (above 3 months of age)

Administration

Use of freshly reconstituted solution is recommended

Interaction

No potentially hazardous interactions reported

Contraindications

Patients with known allergy to Cephalosporins

Side Effects

  • Infrequent and generally mild
  • Transient in nature
  • Rashes
  • Gastrointestinal disturbances
  • Prolonged use may result in overgrowth of non susceptible organisms e.g. Candida

Pregnancy & Lactation

  • US FDA pregnancy category B
  • No adequate and well-controlled studies in pregnant women
  • Excreted in human milk
  • Caution when administered to a nursing woman

Precautions & Warnings

  • Given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis
  • Cephalosporin antibiotics may be given safely to patients who are hypersensitive to penicillin
  • Cross reactions reported
  • Not likely to be a problem at the recommended dose levels

Therapeutic Class

Second generation Cephalosporins

Reconstitution

  • For 750 mg intramuscular injection
  • For 750 mg intravenous injection
  • For 1.5 g intravenous injection

Storage Conditions

Store in a cool, dry place (below 30°C), away from light & moisture

Related Brands